Interestingly, CD109 has been found overexpressed in a number of other cancer types including carcinoma of the uterine cervix [28], lung squamous cell carcinoma [20], cancer of the oral cavity [29], breast cancer [30–31], malignant melanoma [32], myxofibrosarcoma [23], esophageal squamous cell carcinoma [22], squamous cell/adenosquamous carcinomas of the gallbladder [33], hepatocellular carcinoma [34], nasopharyngeal carcinoma [35] and penile squamous cell carcinoma [36]. Here, CD109 is linked to myxofibrosarcoma.